S&P 500   4,564.10 (-0.07%)
DOW   36,132.43 (+0.02%)
QQQ   387.63 (+0.09%)
AAPL   193.28 (-0.07%)
MSFT   369.94 (-0.69%)
META   319.73 (+0.45%)
GOOGL   130.88 (-0.08%)
AMZN   145.49 (-0.95%)
TSLA   245.23 (+2.73%)
NVDA   464.62 (-0.22%)
NIO   8.11 (+9.15%)
BABA   72.49 (+0.15%)
AMD   120.18 (+1.52%)
T   17.11 (-0.64%)
F   10.85 (+2.36%)
MU   73.99 (+0.41%)
CGC   0.69 (+4.16%)
GE   120.68 (+0.37%)
DIS   92.28 (+1.64%)
AMC   7.03 (+0.14%)
PFE   29.37 (+0.96%)
PYPL   60.02 (+3.63%)
XOM   99.48 (-0.96%)
S&P 500   4,564.10 (-0.07%)
DOW   36,132.43 (+0.02%)
QQQ   387.63 (+0.09%)
AAPL   193.28 (-0.07%)
MSFT   369.94 (-0.69%)
META   319.73 (+0.45%)
GOOGL   130.88 (-0.08%)
AMZN   145.49 (-0.95%)
TSLA   245.23 (+2.73%)
NVDA   464.62 (-0.22%)
NIO   8.11 (+9.15%)
BABA   72.49 (+0.15%)
AMD   120.18 (+1.52%)
T   17.11 (-0.64%)
F   10.85 (+2.36%)
MU   73.99 (+0.41%)
CGC   0.69 (+4.16%)
GE   120.68 (+0.37%)
DIS   92.28 (+1.64%)
AMC   7.03 (+0.14%)
PFE   29.37 (+0.96%)
PYPL   60.02 (+3.63%)
XOM   99.48 (-0.96%)
S&P 500   4,564.10 (-0.07%)
DOW   36,132.43 (+0.02%)
QQQ   387.63 (+0.09%)
AAPL   193.28 (-0.07%)
MSFT   369.94 (-0.69%)
META   319.73 (+0.45%)
GOOGL   130.88 (-0.08%)
AMZN   145.49 (-0.95%)
TSLA   245.23 (+2.73%)
NVDA   464.62 (-0.22%)
NIO   8.11 (+9.15%)
BABA   72.49 (+0.15%)
AMD   120.18 (+1.52%)
T   17.11 (-0.64%)
F   10.85 (+2.36%)
MU   73.99 (+0.41%)
CGC   0.69 (+4.16%)
GE   120.68 (+0.37%)
DIS   92.28 (+1.64%)
AMC   7.03 (+0.14%)
PFE   29.37 (+0.96%)
PYPL   60.02 (+3.63%)
XOM   99.48 (-0.96%)
S&P 500   4,564.10 (-0.07%)
DOW   36,132.43 (+0.02%)
QQQ   387.63 (+0.09%)
AAPL   193.28 (-0.07%)
MSFT   369.94 (-0.69%)
META   319.73 (+0.45%)
GOOGL   130.88 (-0.08%)
AMZN   145.49 (-0.95%)
TSLA   245.23 (+2.73%)
NVDA   464.62 (-0.22%)
NIO   8.11 (+9.15%)
BABA   72.49 (+0.15%)
AMD   120.18 (+1.52%)
T   17.11 (-0.64%)
F   10.85 (+2.36%)
MU   73.99 (+0.41%)
CGC   0.69 (+4.16%)
GE   120.68 (+0.37%)
DIS   92.28 (+1.64%)
AMC   7.03 (+0.14%)
PFE   29.37 (+0.96%)
PYPL   60.02 (+3.63%)
XOM   99.48 (-0.96%)

Orthofix Medical Stock Price, News & Analysis (NASDAQ:OFIX)

$10.79
+0.34 (+3.25%)
(As of 11:27 AM ET)
Compare
Today's Range
$10.46
$10.88
50-Day Range
$9.69
$13.07
52-Week Range
$9.57
$23.19
Volume
113,881 shs
Average Volume
433,182 shs
Market Capitalization
$396.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Orthofix Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
34.0% Upside
$14.00 Price Target
Short Interest
Bearish
9.09% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.05mentions of Orthofix Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$101,025 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($3.16) to ($1.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.95 out of 5 stars

Medical Sector

607th out of 948 stocks

Medical Devices Industry

12th out of 17 stocks


OFIX stock logo

About Orthofix Medical Stock (NASDAQ:OFIX)

Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

OFIX Stock Price History

OFIX Stock News Headlines

Orthofix Medical: Under New Management
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Orthofix Medical (NASDAQ:OFIX) Lowered to "Sell" at StockNews.com
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
What Wall Street expects from Orthofix Medical's earnings
Orthofix Shareholder Alert
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/04/2024

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,092
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$14.00
High Stock Price Target
$16.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+34.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-19,750,000.00
Pretax Margin
-19.99%

Debt

Sales & Book Value

Annual Sales
$668.46 million
Cash Flow
$1.77 per share
Book Value
$16.71 per share

Miscellaneous

Free Float
35,029,000
Market Cap
$384.11 million
Optionable
Optionable
Beta
1.02

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives















OFIX Stock Analysis - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price target for 2024?

3 Wall Street research analysts have issued 12-month price targets for Orthofix Medical's shares. Their OFIX share price targets range from $12.00 to $16.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2023?

Orthofix Medical's stock was trading at $20.53 at the beginning of the year. Since then, OFIX stock has decreased by 49.1% and is now trading at $10.45.
View the best growth stocks for 2023 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 4th 2024.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) issued its earnings results on Wednesday, November, 8th. The medical device company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.75) by $0.02. The medical device company had revenue of $184.01 million for the quarter, compared to the consensus estimate of $185.50 million. Orthofix Medical had a negative net margin of 20.39% and a negative trailing twelve-month return on equity of 7.26%.

What ETF holds Orthofix Medical's stock ?

Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Rubric Capital Management LP (9.35%), Armistice Capital LLC (8.07%), AWM Investment Company Inc. (1.63%), Assenagon Asset Management S.A. (1.55%), Emerald Advisers LLC (1.53%) and Emerald Mutual Fund Advisers Trust (1.25%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar.
View institutional ownership trends
.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:OFIX) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -